@dansfera: Is history doomed to repeat itself in clinical research? 🤔 The chatter around massive site network acquisitions is intense, but what *actually* changes this time around? Back in the day, those big consolidations (remember SMOs?) didn't exactly reshape the industry landscape. So, are we seeing a genuine evolution driven by tech, or is this just a familiar loop heading back to where we started years ago? The stakes feel high on this one. #ClinicalResearch #SiteNetworks #MedTech #Pharma #Acquisition